WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
Thank you for supporting BASL2020. Presentations from the Virtual Annual Meeting will soon be available through the On Air events portal using your registration log on.
BASL2020 VIRTUAL ANNUAL MEETING
21st - 23rd September - registration CLOSED
We are looking forward to the BASL2020 Virtual Annual Meeting - Monday 21st - Wednesday 23rd September. Programme sessions will be held across the afternoons of the 3 days which includes the Annual Business Meeting for members on Wednesday. Register > here . Download a programme > here . Registration is also open for the BLNA Virtual Forum taking place on Friday 25th September from 13:30 - 15:30 Register > here .
BASL VIRTUAL ANNUAL MEETING
BASL AND BASL SUB-GROUPS
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.
The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group.
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research.
HCC UK is a multi-disciplinary organisation aiming to promote collaboration in research, education and clinical service development for primary liver cancer. We bring together leading oncologists, liver surgeons, hepatologists, basic scientists, radiologists, pathologists and specialist nurses to lead improvement in the quality of patient care.
BSG - BASL Decompensated Cirrhosis Discharge Bundles 25.8.2020Read more
Download the BSG - BASL Decompensated Cirrhosis Discharge bundle checklists below:
BASL Committee President Elect Post - Voting 2020Read more
Members are invited to vote for their next President Elect.
The successfully nominated candidates are:
• Professor Rajiv Jalan
• Professor David Jones
• Dr Rebecca Jones
If you are a BASL member and have not received a voting link please contact email@example.com .
Deadline for voting 23:59hrs on Thursday 10th September 2020.
Research Excellence Framework 2021Read more
BASL is a nominating body for the Research Excellence Framework (REF) 2021 and the latest date by which we can nominate candidates to the REF 2021 expert sub-panels has been extended to 7th September 2020.
Nominations for a REF sub-panel are aimed at career academics that understand REF2021 and are subject to approval by the BASL Committtee. Any enquries from interested BASL members must be with the Secretariat (firstname.lastname@example.org) by noon on Wednesday 19th August 2020, any received after this date will not be considered.
The current nominations’ call is for additional members and assessors with expertise in specific areas, to ensure each sub-panel has an appropriate breadth of expertise and volume of panel members necessary for the assessment of REF submissions.
It is recommended that you visit the REF2021 website for all of the information on REF sub-panels and roles : https://www.ref.ac.uk/panels/nominating-panel-members/ before contacting BASL.
In memoriam: Professor Neil McIntyre (1934 - 2020)Read more
It is with great sadness that we record the passing of Professor Neil McIntyre on 19th July, aged 86. Neil was born on the 1st of May 1934 in Ferndale in the Rhondda Valley in Wales, and was educated at Rhondda County Grammar School for Boys. In 1951 he started his pre-clinical medical studies at King’s College, London, also achieving a 1st class BSc degree in Physiology in 1955. His clinical studies were at King’s College Hospital Medical School and he graduated MB BS in 1958 with distinctions in Pathology and Applied Pharmacology and Therapeutics. Thus he already had academic aspirations at that time, and indeed was co-author of publications in Nature and the British Journal of Experimental Pathology in 1955 and 1956. His early postgraduate training from 1959 to 1960 was at King’s College Hospital and the Hammersmith Hospital. In 1960 he was called up and was posted as a flight lieutenant in the Royal Air Force Medical Branch to what was then the State of Aden, where he spent three years.
On his return, he was appointed to the Royal Free Hospital and School of Medicine as a Medical Research Council Junior Research Fellow, and Registrar in Medicine to Professor Sheila Sherlock on the Academic Unit. His research led to his MD thesis (“Oral glucose tolerance; the physiological importance of the intestine and liver”)(1967). Meanwhile in 1966 he was awarded a two year Medical Research Council Travelling fellow at Harvard Medical School, working in the Gastrointestinal Unit, at the Massachusetts General Hospital with Professor Kurt Isselbacher.
After this in 1968 he returned to the UK and was appointed Senior Lecturer in the Department of Medicine (Liver Unit) at the Royal Free Hospital and School of Medicine, and was promoted through the years to Reader and then Professor. When Sheila Sherlock retired in October 1983, he was appointed to Chairman of the Department. With the joining of the Royal Free and University College Medical Schools he subsequently became Director of the Division of Hepatology at University College London Medical School and The Royal Free Hospital School of Medicine. He also served as Vice Dean and Clinical Sub-Dean until his retirement in 1999.
Neil enjoyed a long and productive academic career. Remarkably, as an undergraduate, he co-authored the two papers described above on the effects of denervation on the histochemical appearance of cholinesterase at the myoneural junction. Few could claim such a distinction. He and his team’s publications focussed on carbohydrate metabolism and insulin secretion, lipids, lipoproteins and cell membranes (particularly lecithin:cholesterol acyltransferase activity in liver disease), and the effect of lipoprotein changes on cell membranes composition and function. However he was the author of a myriad of clinical papers. His wide ranging interests in hepatology reflected the breadth and depth of his expertise, in a time when a narrow range of research topics was less required. Apart from the topics noted above, his publications ranged from haematological disorders in liver disease, portal hypertension, drug induced liver injury, alcoholic liver disease, genetic diseases, primary biliary cholangitis, computers in hospitals (in 1981), and computerised medical information (in 1974). A search of his seminal papers includes a classic description of haemolytic episodes in children and young people with Wilson's disease (New England Journal of Medicine, 1967).
He was the lead editor of the first edition of the Oxford Textbook of Clinical Hepatology in 1992, and co-editor of the second edition in 1999 with other renowned European hepatologists. This textbook presented a comprehensive account of clinical hepatology comprising more than 150 chapters by international experts in two volumes. Other books included 'Therapeutic Agents and the Liver', edited with Sheila Sherlock (1965); 'The Problem Orientated Medical Record: its Use in Hospital, General Practice, and Medical Education', edited with J.C. Petrie (1979); and
'Lipids and Lipoproteins in Clinical Practice' with David Harry in 1991.
Neil McIntyre had a particular lifelong interest in medical education and was instrumental in developing an up-to-date medical student curriculum at the Royal Free Hospital School of Medicine. He was always a stickler for the practice of clinical medicine and emphasized Oslerian traditions of history taking, and examination. He fostered, with considerable enthusiasm, Problem Orientated Medical Records (POMR), and audit. Amongst his more notable papers in these areas is one in the British Medical Journal which he co-authored with Sir Karl Popper, one of Britain’s foremost philosophers and social commentators, entitled “The critical attitude in medicine: the need for a new ethics”.
Neil also contributed to many learned Societies, including as secretary to the Medical Research Society (1972-1977) and the nascent European Association for the Study of the Liver (EASL)(1975-1977), as well as being a Council Member for Europe of the International Association for the Study of the Liver (IASL)(1978-1982). He was also a member of the Committee for the British Association for the Study of the Liver (1976-1978), as well as a member of Council of the British Society of Gastroenterology and of the Association for the Study of Medical Education. Between 1976 and 1978 he was also President of the Osler club of London. In 2006-2007 he was President of the History of Medicine Society of Wales. Neil was a member of Council and a member of the research committee of the Royal College of Physicians of London. He served as an associate editor of the Journal of Hepatology and on the editorial board of Gut
Neil was renowned for his eclectic interests and chose his subjects with considerable perspicacity. A keen medical historian from his student days, he spent much of his time in retirement working on his treatise “How British Women Became Doctors: The Story of the Royal Free Hospital and its Medical School” and on other historical topics. “I was concerned that the school’s remarkable past might be airbrushed from history and that the hospital might also fail to get the attention it deserved,” he said. In this book he described how a group of young female students formed the London School of Medicine for Women in 1874. They had been blocked from qualifying as doctors through any of the British universities, so took matters into their own hands. The Royal Free, then based at Gray’s Inn Road, stepped up to train the 14 students, admitting the women for clinical studies. This initiative “laid the ‘foundation stone’” for the medical education, qualification and licensing of women in Britain and many other countries.
He wrote of his interest in medical statues: “My interest in medical statues began as a student at King’s in the late 1950s when I wrote a short biography of its founder Robert Bentley Todd for the King’s College Hospital Gazette.” This led (as described in the publication of his lecture at the RCP of London) to his novel ‘hobby’: Neil identified more than 300 statues worldwide, and many busts and other monuments to doctors.
However, clinical medicine, basic science, medical education and medical history were not his only enthusiasms. He was a born and bred Welshman who espoused this part of his being enthusiastically throughout his life. He enjoyed rugby, which he played as a student, and cricket, and continued to play golf for as long as he was able. We remember him practicing his putting across his spacious office in the Academic Unit. Through this and the clinical and academic work Neil encouraged the Royal Free “international family” to continue their strong ties as first engendered by Sheila Sherlock. He will be remembered with respect and affection by numerous colleagues nationally and internationally and by a generation of Royal Free graduates.
Neil married Wendy Anne Kelsey in 1966, the year that she qualified from the Royal Free School of Medicine, and she became a highly respected general practitioner and trainer. They had one son, and one daughter and three grandchildren. His daughter also studied medicine at the Royal Free, continuing its proud tradition of women students.
We send our heartfelt condolences to Wendy, and all his family
Geoff Dusheiko and James Dooley
Trainee Representative for IQILS Steering GroupRead more
An excellent opportunity has arisen to become a trainee member of the IQILS steering group.
Closing date for applications is 28/8/2020.
For more information regarding the position and how to apply please download the advert for the trainee representative here: Download IQILS SG Advert for trainee rep_Aug20.docx.pdf
If you require further information contact email@example.com .
The next meeting of the Immune Special Interest Group (SIG) will take place via Zoom on:
Date: Wednesday 30th September
Time: 13:00 - 16:00
Download a 'draft' agenda here: Download Immune SIG meeting 30.9.20 DRAFT agenda_website.docx.pdf
Immune SIG members who want to Register for the meeting should contact firstname.lastname@example.org .
The National ODN Stakeholder Webinar Event, organised and hosted by HCV Action and the British Viral Hepatitis Group (BVHG) will feature presentations on a range of topics of relevance to ODNs, focusing particularly on overcoming the challenges posed by the coronavirus pandemic.
Attendance will be restricted to a maximum of ten people per non-ODN organisation to ensure a balanced attendance. Joining instructions will be sent to attendees nearer the time.
The agenda for the event (subject to change) can be seen below:
13.30: Welcome - Professor Guruprasad Aithal, President, British Association for the Study of the Liver (BASL)
13.40: National perspective - Professor Graham Foster, National Clinical Lead for ODNs, NHS England / Mark Gillyon-Powell, Head of Programme – HCV Elimination, NHS England/NHS Improvement
14.00: The hepatitis C dashboard: Measuring progressing towards elimination - Dr Ruth Simmonds, Epidemiologist, Public Health England
14.20: ODN perspective on progress towards elimination - Dr Fiona Gordon, ODN Clinical Lead, Bristol & Severn ODN
14.40: Patient perspective - TBC
14.55: Q&A - All above speakers (Chaired by Dr Mark Aldersley, Chair, British Viral Hepatitis Group and Clinical Lead, West Yorkshire ODN)
15.30: Elimination initiatives update – Gilead Sciences - Peter Smethurst, Director - Patient Access to Care, Gilead Sciences
15.50: Elimination initiatives update – MSD - Kuldip Sembhi, Patient Solutions Manager, MSD
16.10: Elimination initiatives update – AbbVie - TBC
16.30: Q&A - All of above speakers (Chaired by Dr Stephen Ryder, Chair, HCV Action and Clinical Lead, Nottingham ODN)
16.55: Meeting summary and close - Professor Guruprasad Aithal, President, British Association for the Study of the Liver
Register for the meeting by visiting the organisers online registration booking website by clicking > HERE.
This half-day event will be followed by a series of shorter webinars focused on particular issues of relevance to hepatitis C services.
The next meeting of the End of Life SIG will take place via Zoom:
Date: Thursday 8th October
Time: 13.30pm – 16.30pm
Download a meeting programme here > Download BASL EOL SIG Programme 8 Oct 2020.pdf
There will be presentations and discussions around the use of long term abdominal drains (including a presentation of the recent REDUCe data by Sumita Verma), the use of cirrhosis MDTs, screening tools to predict poor prognosis in end-stage liver disease and the evolution of the IQILS KPIs for palliative care in liver disease.
To Register for the meeting, or if you have any questions, please contact email@example.com .
Join a virtual Teams meeting on Liver Transplant Pathology to cover the presentations at the Banff meeting held last September 2019
Date: Wednesday 7th October
Time: 15:00 - 17:00
Thanks go to Stefan, Chris and Desley who will present the topics below:
1. Update from Liver Sessions 1 – clinical/diagnostic aspects (Stefan Hubscher)
2. Update from Liver Sessions 2 - molecular/basic aspects (Chris Bellamy)
3. Update on Digital Pathology and Steatosis Assessment (Desley Neil)
There will be an opportunity to ask questions and the meeting is open to all, whether or not you work in a liver transplant centre.
Please indicate your intention to join the meeting by email to Alyn Cratchley; Alyn.firstname.lastname@example.org . Alyn has kindly agreed to moderate the session and will send you a link to join the meeting.
By having a list of participants, we can provide (RCPath) CPD certificates, and request feedback from attendees about the meeting.
Save the Date
The third Workshop of the Liver Regenerative Medicine Network is being planned for Thursday 29th October 2020 at the Institute of Hepatology London.
The aim of the Network is to provide a platform for the Liver Regenerative Medicine research community and facilitate inter/multidisciplinary collaboration across the London Universities and Institutes. The half-day Workshop will highlight the current research in hepatic regenerative medicine and tissue engineering, including cell therapy, organoids, organ-on-a-chip, bio-artificial hepatic systems, bioreactors, biomaterials, cancer modelling and stem cell biology.
The meeting will include two Keynote Sessions and two Bright Sparks Sessions with shorter talks.
Further details can be found on the official webpage for the Workshop here > https://www.liver-research.org.uk/newsletter/conferences-meetings.html
Should you have any questions, please contact Dr Luca Urbani by e-mail at email@example.com .